ConductScience.org, home

Paper3685979

Tumor cell rejection through terminal cell differentiation.

Jimenez JJ and 1 other. Science, 1987. Cited by 38 papers, by iCite.

Cite this record

ConductScience Library. Tumor cell rejection through terminal cell differentiation. Papers, record 3685979. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3685979

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Tumor cell rejection through terminal cell differentiation.
PubMed
Journal
Science
PubMed
Year
1987
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
38
iCite
Relative citation ratio, by iCite
0.87
iCite
Revised in PubMed
2019-06-18
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Jimenez JJJ J
2Yunis AAA A

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Graft RejectionMajor topic
Leukemia, ExperimentalMajor topic
Animals
Animals, Newborn
Cell Differentiation
Cell Division
Cell Line
Cell Survival
Neoplasm Transplantation
Phagocytosis
Rats

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
AM 07114NIADDK NIH HHSUnited StatesPubMed

Source PubMed

Download CSV of grants

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 38 citations.

PMIDTitleJournalYearIn PapersSource
37597697Discovery of 5-sulfonyltetrazoles as neuroblastoma differentiation agents.Bioorg Med Chem Lett2023https://conductscience.org/library/papers/37597697PubMed
30691081The Role of Tissue Transglutaminase in Cancer Cell Initiation, Survival and Progression.Med Sci (Basel)2019https://conductscience.org/library/papers/30691081PubMed
29018329CDDO and ATRA Instigate Differentiation of IMR32 Human Neuroblastoma Cells.Front Mol Neurosci2017https://conductscience.org/library/papers/29018329PubMed
2203794315-Lipoxygenase-1 as a tumor suppressor gene in colon cancer: is the verdict in?Cancer Metastasis Rev2011https://conductscience.org/library/papers/22037943PubMed
21881028Mechanistic contribution of ubiquitous 15-lipoxygenase-1 expression loss in cancer cells to terminal cell differentiation evasion.Cancer Prev Res (Phila)2011https://conductscience.org/library/papers/21881028PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3685979

GET https://conductscience.org/api/papers/v1/3685979/authors